JUVANTIA

Welcome to the Brand page for “JUVANTIA”, which is offered here for In the statement, column 1, line 10, analysis should be inserted. in the statement, column 2, lines 12 and 13, molecule' should be deleted, and, molecular should be inserted.;therapeutically active diagnostic preparations for medical laboratory use; libraries of therapeutically active chemical diagnostic compounds for medical laboratory use; pharmaceutical preparations for the treatment of central nervous system and vascular disorders; veterinary preparations for the treatment of central nervous system and vascular disorders; biological diagnostic preparations for clinical medical or veterinary laboratory purposes;chemical diagnostic preparations for scientific use; libraries of chemical diagnostic compounds for research use; chemical reagents for research use; chemical diagnostic substances and preparations for use in [ analyses ] * analysis * in laboratories for research use; biological diagnostic preparations for research use;scientific and industrial research, particularly research relating to pharmaceuticals and receptor studies; chemical analysis and research, particularly pharmaceutical screening assays and other bioaffinity assays; pre-synthetic drug design for others; design for others in the field of [ molecule ] * molecular * modelling;.

Its status is currently believed to be active. Its class is unavailable. “JUVANTIA” is believed to be currently owned by “Oy Juvantia Pharma Ltd.”


Owner:
OY JUVANTIA PHARMA LTD.
Owner Details
Description:
In the statement, column 1, line 10, ANALYSIS should be inserted. In the statement, column 2, lines 12 and 13, MOLECULE' should be deleted, and, MOLECULAR should be inserted.;THERAPEUTICALLY ACTIVE DIAGNOSTIC PREPARATIONS FOR MEDICAL LABORATORY USE; LIBRARIES OF THERAPEUTICALLY ACTIVE CHEMICAL DIAGNOSTIC COMPOUNDS FOR MEDICAL LABORATORY USE; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM AND VASCULAR DISORDERS; VETERINARY PREPARATIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM AND VASCULAR DISORDERS; BIOLOGICAL DIAGNOSTIC PREPARATIONS FOR CLINICAL MEDICAL OR VETERINARY LABORATORY PURPOSES;CHEMICAL DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC USE; LIBRARIES OF CHEMICAL DIAGNOSTIC COMPOUNDS FOR RESEARCH USE; CHEMICAL REAGENTS FOR RESEARCH USE; CHEMICAL DIAGNOSTIC SUBSTANCES AND PREPARATIONS FOR USE IN [ ANALYSES ] * ANALYSIS * IN LABORATORIES FOR RESEARCH USE; BIOLOGICAL DIAGNOSTIC PREPARATIONS FOR RESEARCH USE;SCIENTIFIC AND INDUSTRIAL RESEARCH, PARTICULARLY RESEARCH RELATING TO PHARMACEUTICALS AND RECEPTOR STUDIES; CHEMICAL ANALYSIS AND RESEARCH, PARTICULARLY PHARMACEUTICAL SCREENING ASSAYS AND OTHER BIOAFFINITY ASSAYS; PRE-SYNTHETIC DRUG DESIGN FOR OTHERS; DESIGN FOR OTHERS IN THE FIELD OF [ MOLECULE ] * MOLECULAR * MODELLING;
Categories: STATEMENT